EDG004

· Edgemont Pharmaceuticals, LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for EDG004, covering 2018-09-26 to 2018-09-26. Get the full timeline:

Most recent: Clinical Trial Update: EDG004 Treatment of Adult Patients With Generalized Anxiety Disorder (GAD) [Phase 3]